{
    "code": 0,
    "data": [
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earning call Transcript for the quarter and nine month ended December 31 2025",
            "news_id": "a1bdea5b-6005-40a9-a710-b978dd800ade",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=785902df-3c4d-47d2-a4ae-a2f88f8a2207.pdf",
            "news_date": "2026-02-09 14:46:20",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Earnings call pertaining to the Unaudited Financial Results (Consolidated and Standalone) for the quarter and nine months December 31 2025",
            "news_id": "cd49283a-be63-4dd1-8300-bd3192b67508",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=93b8eed5-9a7e-4ad4-a637-3524baa50431.pdf",
            "news_date": "2026-02-06 21:51:45",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation Q3 FY26",
            "news_id": "4927dae5-fb01-4495-beba-121294da095f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aa67a964-c0c4-457c-9c54-532ec458ca4b.pdf",
            "news_date": "2026-02-06 08:20:38",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Standalone\r\n& Consolidated Financial Results For The Quarter And Nine Months Ended December 31 2025",
            "news_body": "Unaudited standalone  and Consolidated  Results for Q3 FY 26",
            "news_id": "c58f3be0-249e-40e4-b4cd-2c04fe299542",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=28849810-27e1-49f6-a3fa-c13416fe20e3.pdf",
            "news_date": "2026-02-05 21:09:14",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings Call Transcript",
            "news_id": "0ca4bfb9-090d-411d-8296-a36dc28515bc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c2273155-21a3-4560-9465-b3ce9ec2c8f6.pdf",
            "news_date": "2025-11-21 12:17:38",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Updated Investor Presentation",
            "news_id": "8438580d-35ca-4511-aba3-f2fe4697a761",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=31845c8a-1041-421f-b5e9-9cca1abdc372.pdf",
            "news_date": "2025-11-18 23:03:41",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for Q2 FY 26 Results",
            "news_id": "1377aaae-5ec9-4e34-957d-da7d5d2b49f9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=faecb00c-1f79-4dd2-a81d-d3fb6336fbae.pdf",
            "news_date": "2025-11-17 16:14:47",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Q2 FY26 Results",
            "news_body": "Q2 FY26 Results",
            "news_id": "b111da73-195c-4849-836e-1bd5ea89e58d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5ee5b962-937b-499e-992e-f5c5da480312.pdf",
            "news_date": "2025-11-14 20:52:38",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings call Transcript",
            "news_id": "6e3359d0-26b7-44e4-9aea-5ff721b1398e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b0f8d68f-917e-4559-85e9-2ae114b069b7.pdf",
            "news_date": "2025-08-13 18:00:01",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earning call Transcript",
            "news_id": "f8c7e712-0891-4ad5-816e-474779bffd63",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c311c218-9013-4c3a-91d1-2c26d7e9e05e.pdf",
            "news_date": "2025-08-13 12:56:21",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Earnings call pertaining to the Unaudited Financial Results (Consolidated and Standalone) for the quarter ended June 30 2025",
            "news_id": "3b90c1d0-2fdf-4bee-8efc-5f8dd5dd9838",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bf369d20-39f4-4723-984f-8d6debfbe5c0.pdf",
            "news_date": "2025-08-11 11:44:39",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Standalone & Consolidated Financial Results For The Quarter Ended June 30 2025",
            "news_body": "Financial Results for Q1 FY26",
            "news_id": "c50cf000-45cc-404a-85f9-b4d96ba81ff7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f3b4b59d-2d23-4dd4-a169-ab80c3de937f.pdf",
            "news_date": "2025-08-08 12:49:02",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings call Transcript",
            "news_id": "d2973daa-157f-489c-b78a-0d9b36fe3113",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=336e79a5-abde-4aaa-b9a9-d1f5bee5a34a.pdf",
            "news_date": "2025-05-29 12:57:18",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation Q4 FY 25",
            "news_id": "1b089eb2-e69b-47ca-a328-e2c010283cca",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=58080066-33d3-49be-8c38-e66df62f1330.pdf",
            "news_date": "2025-05-20 21:47:39",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results",
            "news_body": "Results",
            "news_id": "670af7f5-0dd7-491a-a7cc-c1cef5248344",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3fa066d0-3040-4022-88c5-4760985bc9cf.pdf",
            "news_date": "2025-05-20 13:22:05",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor presentation Q3FY25",
            "news_id": "9b0bfc8a-ff47-44de-bfb6-66a8c6ef3ef0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bae82f92-33a6-4aff-9153-0c42d50475b7.pdf",
            "news_date": "2025-02-11 13:53:30",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On February 11 2025 Along With Unaudited Standalone And\r\nConsolidated Financial Results For The Quarter And Nine Months Ended December 31 2024",
            "news_body": "Unaudited standalone and consolidated financial results -Q3 FY 25",
            "news_id": "731868b9-d9db-4d97-ad1c-f7a647e27de7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a2b45a0c-9c7a-4e11-b594-e021c9f0e5d7.pdf",
            "news_date": "2025-02-11 13:13:17",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earning Call Transcript: Q2 FY 25",
            "news_id": "dfb06618-ba88-453c-861d-bb5763cae190",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=50d7272f-14a2-47ef-af9a-83a1313712b2.pdf",
            "news_date": "2024-11-22 18:53:43",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Earnings call and Earnings presentation pertaining to the Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2024",
            "news_id": "13e4bc76-020c-4ed3-937e-f99fb7d07089",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9fd213ec-096b-45e0-bc8f-f9b788053526.pdf",
            "news_date": "2024-11-14 17:52:09",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "588b2f5f-2e16-4f6d-90cc-ad0effe07a70",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ee234a00-3da8-4005-9bc5-7334d8f50e50.pdf",
            "news_date": "2024-11-13 21:53:48",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Q2FY25 Results",
            "news_body": "Q2FY25 Results",
            "news_id": "49316c73-2f8a-4bda-a0be-cc2300ccdc9b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0d5b604b-4f25-4cde-b9e7-2480c3a021b0.pdf",
            "news_date": "2024-11-13 20:30:44",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of conference call -October 01, 2024",
            "news_id": "d7f529e8-9c64-47d0-98b3-7487f01417b3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=22cdf673-da7a-4add-a771-655eafcc8528.pdf",
            "news_date": "2024-10-02 18:34:00",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "e7b85ca6-adb7-4350-9089-37a5b58cd907",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=80c11943-5d3a-4825-8d4f-8890523b5194.pdf",
            "news_date": "2024-09-27 00:39:23",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings call transcript Dated-August 16, 2024",
            "news_id": "b31fb579-6bd5-43ed-a066-fbd55c391623",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=04a0ba13-aa94-4d48-b430-2ff04e0fe95a.pdf",
            "news_date": "2024-08-21 12:48:54",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "15199574-6955-45cb-831a-ebb5665da8d1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ffcf1a9f-56c7-45b3-b4a8-f602a7f30e2b.pdf",
            "news_date": "2024-08-15 21:48:09",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Sequent Results Q1 FY2024-25",
            "news_body": "Sequent Result Q1 FY 2024-25",
            "news_id": "9782768f-2203-41db-8b6a-85a5ad26fbfa",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d2a1e4b5-b86d-44da-95d8-749b0d1b86f5.pdf",
            "news_date": "2024-08-14 19:49:21",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the earnings call and earnings presentation made on May 16, 2024, on Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended March31, 2024, is available on the Company's website.",
            "news_id": "6a5df906-1f22-42a9-a389-098afa5f4408",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=76f60cb1-9e4d-4f38-9206-0bffab1e47d5.pdf",
            "news_date": "2024-06-14 19:47:10",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earning Call Transcript for the quarter and year ended March 31, 2024",
            "news_id": "2c4ff3ab-a944-4522-9679-0949cda004f3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=59bf31de-a479-472d-9334-2af03f5ae344.pdf",
            "news_date": "2024-05-20 17:31:24",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Earning Presentation Q4 FY24",
            "news_id": "53993317-c9d5-4aa6-9273-0db5dc388527",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8bfb359f-e77a-4890-b609-e97e7f11810b.pdf",
            "news_date": "2024-05-15 21:15:06",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On May 15, 2024 Along With Audited Standalone &<BR> Consolidated Financial Results For The Quarter And Year Ended March 31, 2024",
            "news_body": "1. Audited Consolidated Financial Results along with Independent Auditor's Review Report issued<BR> by the Statutory Auditors of the Company for the quarter and year ended March 31, 2024 with<BR> an unmodified opinion.<BR> 2. Audited Standalone Financial Results along with Independent Auditor's Review Report issued by<BR> the Statutory Auditors of the Company for the quarter and year ended March 31, 2024 with an<BR> unmodified opinion.<BR> 3. The Board has not recommended any dividend for F.Y. 2023-24.",
            "news_id": "ddc4e820-64e3-4c72-81af-6fd2de4ac58c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=836ca3cf-2c7e-43d0-97d7-e1e1f801e5bf.pdf",
            "news_date": "2024-05-15 20:15:15",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On May 15, 2024 Along With Audited Standalone &<BR> Consolidated Financial Results For The Quarter And Year Ended March 31, 2024",
            "news_body": "Audited standalone and Consolidated Financial Results for the quarter and Year ended March 31, 2024 <BR>",
            "news_id": "b7df9106-4ff7-4a8b-9323-996baa9e187a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4d2b46a0-d546-4a6d-8550-4dfeef968f62.pdf",
            "news_date": "2024-05-15 20:09:49",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Intimation of Earnings Call Transcript as per Regulation 30  of SEBI (LODR) Regulations, 2015",
            "news_id": "948a2788-74cf-4493-b804-5de575963135",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4744d9b0-6108-4de1-ad27-0ed483129c64.pdf",
            "news_date": "2024-02-22 12:56:51",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the earnings call and earnings presentation made on February 15, 2024, on Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and nine months ended December 31, 2023, is available on the Company's website",
            "news_id": "551bbfd7-1d1f-4036-b2b0-b5b5ccd8497c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3452d4bb-eff1-4e2f-9f6b-d443cc195c66.pdf",
            "news_date": "2024-02-15 17:46:29",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for quarter ended 31st December 2023",
            "news_id": "95070ef8-90b7-43cd-93a3-cf019b5e43dc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2d03397b-9730-476c-b009-db9d60cc6192.pdf",
            "news_date": "2024-02-15 11:13:38",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For Quarter And Nine Months Ended 31 December 2023",
            "news_body": "Financial results for quarter ended December 31 2023",
            "news_id": "2f5aee21-be27-491f-a08d-bcbf115304f4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bfcace9b-0bdc-4375-87b9-387de926068a.pdf",
            "news_date": "2024-02-13 20:53:59",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the Earnings Call Transcript pertaining to the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2023.",
            "news_id": "867dc4d7-ed04-4e1a-88d4-5d225c6d9ea5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eac90fd1-16a8-41ae-8335-9286207f2749.pdf",
            "news_date": "2023-11-13 16:24:33",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "The audio recording of the earnings call and earnings presentation made on November 07, 2023, on Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2023, is available on the Company's website.",
            "news_id": "d202971b-7707-4481-b3ea-077a0834e991",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8a89a3d7-19d9-44e5-a823-0c2eb5145746.pdf",
            "news_date": "2023-11-07 13:06:49",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor presentation on Unaudited standalone and consolidated financials of quarter and half year ended September 30, 2023",
            "news_id": "d11fa3f4-4e9c-481c-9bc1-1ed41f412bdf",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=13f91a89-4eb3-4577-ac6a-dafff7d056a0.pdf",
            "news_date": "2023-11-06 22:25:43",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On November 06, 2023 Along With Unaudited Standalone & Consolidated Financial Results For The Quarter And Half Year Ended September 30, 2023.",
            "news_body": "Disclosure of unaudited consolidated and standalone financial results for quarter and half year ended September 30, 2023",
            "news_id": "8d0e8fb3-641d-486c-8c28-22f6f69e0032",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8b606724-1387-44ac-b14e-c505a5deb4fd.pdf",
            "news_date": "2023-11-06 22:02:42",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30 (6) of the Security and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulation 2015, we were enclosed herewith the Earning call transcript pertaining to the Unaudited Financial Results of the Company for quarter ended June 30, 2023.Kindly take the same on record",
            "news_id": "9e1a82ca-3a43-4694-9eaa-9758027e7e33",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=06bdee78-c5f6-4cd9-a7d7-1e9afaf4b556.pdf",
            "news_date": "2023-08-18 19:04:19",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the earnings call and earnings presentation made on August 11, 2023, on Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2023, is available on the Company's website.",
            "news_id": "99ea499f-eee9-42c4-bad9-17e5302a3c50",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4df4609e-e5de-4dd2-9fed-8afd09e0b909.pdf",
            "news_date": "2023-08-11 15:19:59",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Regulation 30 (read with Part A of schedule III) of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board of Director at its meeting held today, inter-alia, approved the Press Release and Investor Presentation on Unaudited Standalone and Consolidate Financial Results for the quarter ended June 30, 2023.",
            "news_id": "ccb51071-c224-4bca-b835-d7f931f1b7e2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bf1da31a-8fc9-4291-b993-72b00d2f4b66.pdf",
            "news_date": "2023-08-10 22:52:39",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended June 30, 2023",
            "news_body": "Financial Results for the quarter ended June 30, 2023",
            "news_id": "5e085555-5957-47b7-809a-0f4d9f322f14",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=254e3741-2ce5-4fd1-9264-befdae965587.pdf",
            "news_date": "2023-08-10 22:13:59",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations andDisclosure Requirements) Regulations, 2015, we are enclosing herewith the Earnings Call Transcriptpertaining to the audited Financial Results of the Company for quarter and year ended March 31, 2023.The same is also available on the Company's website at https://www.sequent.in/pdf/financial/2022-2023/Q4/SequentSci-Earnings-May24-2023.pdf",
            "news_id": "220c79e0-8aae-422e-89bf-355c58f81186",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=787800f6-59ca-4b33-856a-78e4bd07c4ac.pdf",
            "news_date": "2023-05-26 18:20:24",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations andDisclosure Requirements) Regulations, 2015, the audio recording of the earnings call and earningspresentation made on May 24, 2023, on Audited Financial Results (Consolidated and Standalone) ofthe Company for the quarter and year ended March 31, 2023, is available on the Company's website",
            "news_id": "93cd01a5-be8f-40f1-a9ba-a9cdee89a70f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0bbe7cd5-0f32-44a8-96d3-e274e7f7f2a5.pdf",
            "news_date": "2023-05-24 17:48:26",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the Investor Presentation on Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2023.",
            "news_id": "e8e10590-ac52-4a1b-9d08-df99ef8f9055",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ab7d0033-9f2f-467c-8f9e-2ee946401e7c.pdf",
            "news_date": "2023-05-23 21:59:34",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On May 23, 2023 Along With Audited Standalone & Consolidated Financial Results For The Quarter And Year Ended March 31, 2023",
            "news_body": "Pursuant to Regulation 30 (read with Part A of Schedule III) and Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board of Directors at its Meeting held today, inter-alia, considered and approved the Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2023. In this regard, kindly find enclosed the following: <BR> <BR> 1. Audited Consolidated Financial Results along with Independent Auditor's Review Report issued by the Statutory Auditors of the Company for the quarter and year ended March 31, 2023 with an unmodified opinion.<BR> 2. Audited Standalone Financial Results along with Independent Auditor's Review Report issued by the Statutory Auditors of the Company for the quarter and year ended March 31, 2023 with an unmodified opinion.<BR> 3. The Board has not recommended any dividend for F.Y. 2022-23.<BR>",
            "news_id": "022fd393-8895-4f05-9bf6-b3560f5a04a9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=136a4488-b6f5-4060-8e78-fd3fd1fa0e1d.pdf",
            "news_date": "2023-05-23 20:19:41",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On May 23, 2023 Along With Audited Standalone & Consolidated Financial Results For The Quarter And Year Ended March 31, 2023",
            "news_body": "Pursuant to Regulation 30 (read with Part A of Schedule III) and Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board of Directors at its Meeting held today, inter-alia, considered and approved the Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2023. In this regard, kindly find enclosed the following: <BR> <BR> 1. Audited Consolidated Financial Results along with Independent Auditor's Review Report issued by the Statutory Auditors of the Company for the quarter and year ended March 31, 2023 with an unmodified opinion.<BR> 2. Audited Standalone Financial Results along with Independent Auditor's Review Report issued by the Statutory Auditors of the Company for the quarter and year ended March 31, 2023 with an unmodified opinion. <BR>",
            "news_id": "19899e85-8204-48b8-94d3-dc6ace9c57c1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=31c11106-14e3-4f71-ab4d-ab00675fb619.pdf",
            "news_date": "2023-05-23 20:16:46",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the Earnings Call Transcript pertaining to the Unaudited Financial Results of the Company for quarter and nine months ended December 31, 2022.",
            "news_id": "f0c78f6c-2e40-4ea7-9482-dd7a96e54474",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b71cdeff-1145-4682-b223-14d68e71eed7.pdf",
            "news_date": "2023-02-21 11:19:19",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the earnings call and earnings presentation made on February 15, 2023, on Unaudited Financial Results (Consolidated and Standalone) of the Company for the quarter and nine months ended December 31, 2022, is available on the Company's website.",
            "news_id": "588bd529-2e7b-4093-b39b-f2ae1aa6c781",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d697ca76-da57-4be5-8b77-29fa4e11bb1d.pdf",
            "news_date": "2023-02-15 12:18:03",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2022",
            "news_body": "The Board of Directors at its meeting held today, viz. February 14, 2023, has considered and approved the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2022. A copy of the said results along with the limited review report and , is enclosed.A press release along with the investor presentation issued in this regard, is also enclosed.",
            "news_id": "ad6c74ba-c72b-4893-ba37-71e558307b52",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c2f95fbb-b71e-4d49-b7fb-a80a23d51ca1.pdf",
            "news_date": "2023-02-14 17:56:07",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Compliance Under Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.",
            "news_body": "In terms of Regulation 23(9) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose disclosure of Related Party Transactions on a consolidated basis, in the format specified in the accounting standards for the half year ended September 30, 2022.",
            "news_id": "39577b46-b98f-413e-bd22-17f7dbbec514",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bc536721-aaa2-471d-bfca-ce77507b1acc.pdf",
            "news_date": "2022-11-21 18:56:39",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Sequent Scientific Limited has informed the Exchange about Transcript of Analysts/Institutional Investor Meet/Con. Call pertaining to the Unaudited Financial Results for quarter and half year ended September 30, 2022.",
            "news_id": "c25db8e8-3324-4593-bd89-b9700c040da9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5bf215a1-6257-4d03-8928-6511f3d57279.pdf",
            "news_date": "2022-11-14 14:41:41",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the earnings call and earnings presentation made on November 08, 2022, on Unaudited Financial Results (Consolidated and Standalone) of the Company for the quarter and half year ended September 30, 2022, is available on the Company's website",
            "news_id": "9c6d4ee3-19b1-43df-84ca-94599d9813e7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f4b5c166-f27c-4ae9-8057-7d2c37a48232.pdf",
            "news_date": "2022-11-08 20:04:36",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On November 07, 2022, Along With Unaudited Standalone & Consolidated Financial Results For The Quarter And Half Year Ended September 30, 2022 And Press Release",
            "news_body": "Sequent Scientific Limited has informed the Exchange that the Board of Directors of the Company at their meeting held today, have inter alia considered and approved the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2022.",
            "news_id": "ebd55af2-9199-4936-9960-daacf15cf583",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1625a69e-a910-42c4-8239-a53132fc453f.pdf",
            "news_date": "2022-11-07 20:36:34",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Sequent Scientific Limited has informed the Exchange about Transcript of Analysts/Institutional Investor Meet/Con. Call pertaining to the Unaudited Financial Results for quarter ended June 30, 2022",
            "news_id": "98e03d75-6117-4b43-af31-09720c3878fc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0c2590d5-246f-46cc-b3cf-495d3ccc98be.pdf",
            "news_date": "2022-08-16 14:57:02",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On August 08, 2022 Along With Unaudited Standalone & Consolidated Financial Results For The Quarter Ended June 30, 2022 And Press Release",
            "news_body": "Pursuant to Regulation 30 (read with Part A of Schedule III) and Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board of Directors at its Meeting held today, inter-alia, considered and approved the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2022.",
            "news_id": "05660b4a-7c27-4b31-84f2-e9429d74f60c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6154e20a-d6c9-40c6-b680-420b34d580de.pdf",
            "news_date": "2022-08-08 21:36:04",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On August 08, 2022 Along With Unaudited Standalone & Consolidated Financial Results For The Quarter Ended June 30, 2022 And Press Release",
            "news_body": "Pursuant to Regulation 30 (read with Part A of Schedule III) and Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board of Directors at its Meeting held today, inter-alia, considered and approved the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2022.",
            "news_id": "c809ff04-5e23-4f6b-9799-ceb121e6b12a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6f548c3d-5530-4f48-afa0-e3aa18e1cd61.pdf",
            "news_date": "2022-08-08 21:32:59",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Compliance Under Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "In terms of Regulation 23(9) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose disclosure of Related Party Transactions on a consolidated basis, in the format specified in the accounting standards for the half year ended March 31, 2022.",
            "news_id": "d9d00557-136b-4040-90b2-2bcd2cc81068",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=23b24939-9e02-415d-ae19-21bc5592108d.pdf",
            "news_date": "2022-06-09 18:48:43",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the Earnings Call Transcript pertaining to the Audited Financial Results for quarter and year ended March 31, 2022.The same is also available on the Company's website at https://sequent.in/investor-relations.aspx",
            "news_id": "0907cd0b-039f-46a7-b7d3-c7be82fbaa53",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=687fecb6-5761-42b1-8bcb-04daae7401ab.pdf",
            "news_date": "2022-05-30 18:23:25",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the earnings call and earnings presentation made on May 26, 2022, on Audited Financial Results (Consolidated and Standalone) of the Company for the quarter and year ended March 31, 2022, is available on the Company's website at https://sequent.in/investor-relations.aspx",
            "news_id": "36956a78-849a-4987-a7af-ddda1e7c9639",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=556b39ab-754c-4e62-b4f7-15afbeae93e0.pdf",
            "news_date": "2022-05-26 19:18:41",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On May 25, 2022 Along With Audited Standalone & Consolidated Financial Results And Press Release For The Quarter And Year Ended March 31, 2022",
            "news_body": "Pursuant to Regulation 30 (read with Part A of Schedule III) and Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board of Directors at its Meeting held today, inter-alia, considered and approved the Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2022. In this regard, kindly find enclosed the followingAudited Consolidated Financial Results along with Independent Auditor's Review Report issuedby the Statutory Auditors of the Company for the quarter and year ended March 31, 2022.2. Audited Standalone Financial Results along with Independent Auditor's Review Report issued bythe Statutory Auditors of the Company for the quarter and year ended March 31, 2022.3. A copy of Press Release and Investors Presentation on Audited Standalone and ConsolidatedFinancial Results for the quarter and year ended March 31, 2022",
            "news_id": "41c82707-b13d-43ac-b390-e87fe8bb13c6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e3e0fe79-0cdb-4686-8b53-22c33edf4c26.pdf",
            "news_date": "2022-05-25 21:15:32",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On May 25, 2022 Along With Audited Standalone & Consolidated Financial Results And Press Release For The Quarter And Year Ended March 31, 2022",
            "news_body": "Pursuant to Regulation 30 (read with Part A of Schedule III) and Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board of Directors at its Meeting held today, inter-alia, considered and approved the Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2022. In this regard, kindly find enclosed the following:<BR> 1. Audited Consolidated Financial Results along with Independent Auditor's Review Report issued<BR> by the Statutory Auditors of the Company for the quarter and year ended March 31, 2022.<BR> 2. Audited Standalone Financial Results along with Independent Auditor's Review Report issued by<BR> the Statutory Auditors of the Company for the quarter and year ended March 31, 2022.<BR> 3. A copy of Press Release and Investors Presentation on Audited Standalone and Consolidated<BR> Financial Results for the quarter and year ended March 31, 2022.",
            "news_id": "4f86cf5e-290d-44e6-ae15-841506e7cf90",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cbd0c1ac-bdc6-4831-9467-38898eb425b0.pdf",
            "news_date": "2022-05-25 21:08:33",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On February 11, 2022, Along With Unaudited Standalone & Consolidated Financial Results And Press Release For The Quarter And Nine Months Ended December 31, 2021",
            "news_body": "Pursuant to Regulation 30 (read with Part A of Schedule III) and Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board of Directors at its Meeting held today, inter-alia, considered and approved the Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31, 2021.",
            "news_id": "a419b869-388f-466e-be81-9a111af951b5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6f2027d7-5646-4b98-95a8-20769855173e.pdf",
            "news_date": "2022-02-11 20:06:56",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On February 11, 2022, Along With Unaudited Standalone &<BR> Consolidated Financial Results And Press Release For The Quarter And Nine Months Ended<BR> December 31, 2021",
            "news_body": "Pursuant to Regulation 30 (read with Part A of Schedule III) and Regulation 33 of the Securities and<BR> Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would<BR> like to inform you that the Board of Directors at its Meeting held today, inter-alia, considered and<BR> approved the Unaudited Standalone and Consolidated Financial Results for the quarter and nine months<BR> ended December 31, 2021.",
            "news_id": "8ebed604-3fdd-40b1-bc13-3f7f0a37e56b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b5857f89-6ce5-46dc-9bb1-eb2d85c25fa6.pdf",
            "news_date": "2022-02-11 20:01:50",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Compliance Under Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "In terms of Regulation 23(9) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose disclosure of Related Party Transactions on a consolidated basis, in the format specified in the accounting standards for the half year ended September 30, 2021.<BR> <BR> You are requested to take the same on record.",
            "news_id": "3f0fb7ad-7bb6-4f78-beb4-226fef0779aa",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=037840f2-ce2f-4e58-837a-847e0c66fda9.pdf",
            "news_date": "2021-11-27 13:04:43",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On November 01, 2021, Along With Unaudited Standalone &Consolidated Financial Results And Press Release For The Quarter And Half Year Ended<BR> September 30, 2021",
            "news_body": "Pursuant to Regulation 30 (read with Part A of Schedule III) and Regulation 33 of the Securities and<BR> Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would<BR> like to inform you that the Board of Directors at its Meeting held today, inter-alia, considered and<BR> approved the Unaudited Standalone and Consolidated Financial Results for the quarter and half<BR> year ended September 30, 2021.",
            "news_id": "87b396e6-7464-44dd-be77-9a64c269db5c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=405884ce-9d71-4750-9bda-f408d13d107f.pdf",
            "news_date": "2021-11-01 20:00:41",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On November 01, 2021, Along With Unaudited Standalone & Consolidated Financial Results And Press Release For The Quarter And Half Year Ended September 30, 2021",
            "news_body": "Pursuant to Regulation 30 (read with Part A of Schedule III) and Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board of Directors at its Meeting held today, inter-alia, considered and approved the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2021.",
            "news_id": "2e942e66-c449-4a6a-8cbf-612c04feed94",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1af2326e-3758-4a80-bded-1a89448a355c.pdf",
            "news_date": "2021-11-01 19:54:32",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended June 30, 2021",
            "news_body": "Pursuant to Regulation 30 (read with Part A of Schedule III) and Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board of Directors at its Meeting held today, inter-alia, considered and approved the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2021. In this regard, kindly find enclosed the following:<BR> <BR> 1. Unaudited Consolidated Financial Results along with Independent Auditor's Review Report issued by the Statutory Auditors of the Company for the quarter ended June 30, 2021.<BR> 2. Unaudited Standalone Financial Results along with Independent Auditor's Review Report issued by the Statutory Auditors of the Company for the quarter ended June 30, 2021.<BR> 3. A copy of Press Release and Investors Presentation on Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2021.",
            "news_id": "7733414f-04f9-4397-9084-4086a31e3eec",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=38224f3f-f5b1-415d-9a9b-50d89b6ef976.pdf",
            "news_date": "2021-08-10 19:12:18",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Compliance Under Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "Dear Sir/ Madam,<BR> In terms of Regulation 23(9) of Securities and Exchange Board of India (Listing Obligations and Disclosure<BR> Requirements) Regulations, 2015, we enclose disclosure of Related Party Transactions on a consolidated<BR> basis, in the format specified in the accounting standards for the half year ended March 31, 2021.<BR> You are requested to take the same on record.",
            "news_id": "fb2ae633-ed60-4e60-9741-f73987c7f56f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=55734806-f74a-4701-a143-986f707d2f35.pdf",
            "news_date": "2021-07-30 14:15:40",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On June 30, 2021 Along With Audited Standalone & Consolidated Financial Results And Press Release For The Quarter And Year Ended March 31, 2021",
            "news_body": "Pursuant to Regulation 30 (read with Part A of Schedule III) and Regulation 33 of the Securities and<BR> Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would<BR> like to inform you that the Board of Directors at its Meeting held today, inter-alia, considered and<BR> approved the Audited Standalone and Consolidated Financial Results for the quarter and year ended<BR> March 31, 2021. In this regard, kindly find enclosed the following",
            "news_id": "bd76c182-48e4-416a-89ad-ef6529a782c0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fb23311d-ac9a-4acf-ba2b-346e7df5fc98.pdf",
            "news_date": "2021-06-30 22:40:24",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIYASH",
            "disp": "Viyash Scientific",
            "bse_code": 512529,
            "isin": "INE807F01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On June 30, 2021 Along With Audited Standalone & Consolidated<BR> Financial Results And Press Release For The Quarter And Year Ended March 31, 2021",
            "news_body": "Pursuant to Regulation 30 (read with Part A of Schedule III) and Regulation 33 of the Securities and<BR> Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would<BR> like to inform you that the Board of Directors at its Meeting held today, inter-alia, considered and<BR> approved the Audited Standalone and Consolidated Financial Results for the quarter and year ended<BR> March 31, 2021. <BR>",
            "news_id": "bdce2777-c6f9-475d-9111-4b8b5ba53303",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d6b92d3d-5328-4129-8f9c-0eec6043a1cf.pdf",
            "news_date": "2021-06-30 22:37:42",
            "seo": "sequent-scientific-ltd",
            "ltp": 216.11,
            "ch": 11.100000000000023,
            "pch": 5.414370030730219,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 14296,
            "exch": "NSE",
            "seg": "E"
        }
    ],
    "remarks": ""
}